Filing Details

Accession Number:
0001209191-14-070432
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-20 18:19:42
Reporting Period:
2014-11-19
Filing Date:
2014-11-20
Accepted Time:
2014-11-20 18:19:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Pharma Plc HZNP Pharmaceutical Preparations (2834) 272179987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1342821 Jeff Himawan C/O Horizon Pharma Plc
Adelaide Chambers, Peter Street
Dublin L2 8
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2014-11-19 3,450,000 $12.05 1,614,731 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Footnotes
  1. Due to a clerical error, the number of ordinary shares reported in the Reporting Person's previous Form 4 filed September 22, 2014 was inadvertently overstated by 96 shares. The number of ordinary shares indirectly owned by the Reporting Person prior to this transaction was 5,064,731.
  2. The securities are held directly by Essex Woodlands Health Ventures Fund VII, L.P. (the "Fund"). The Reporting Person is a manager of Essex Woodlands Health Ventures VII, L.L.C., which is the general partner of Essex Woodlands Health Ventures VII, L.P., the general partner of the Fund. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.